TY - JOUR
T1 - Lavdosisacetylsalicylsyre til forebyggelse af præeklampsi
AU - Andersen, Maria Færch
AU - Rode, Line
AU - Christiansen, Iben Louise Riishede
AU - Tabor, Ann
AU - Ekelund, Charlotte Kvist
N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.
PY - 2024/4/29
Y1 - 2024/4/29
N2 - Pre-eclampsia affects 3-4% of pregnancies and is associated with maternal and infant mortality and morbidity. High-risk pregnancies in Denmark are recommended prophylactic low-dose acetylsalicylic acid (LDA). If new screening algorithms are implemented, LDA will be recommended to around 10% of pregnant women. The use of LDA may slightly increase the risk of minor bleeding disturbances. Otherwise, there is a lot of promising data regarding the safety of LDA use during pregnancy, as argued in this review.
AB - Pre-eclampsia affects 3-4% of pregnancies and is associated with maternal and infant mortality and morbidity. High-risk pregnancies in Denmark are recommended prophylactic low-dose acetylsalicylic acid (LDA). If new screening algorithms are implemented, LDA will be recommended to around 10% of pregnant women. The use of LDA may slightly increase the risk of minor bleeding disturbances. Otherwise, there is a lot of promising data regarding the safety of LDA use during pregnancy, as argued in this review.
KW - Humans
KW - Pre-Eclampsia/prevention & control
KW - Pregnancy
KW - Aspirin/administration & dosage
KW - Female
KW - Platelet Aggregation Inhibitors/administration & dosage
UR - https://ugeskriftet.dk/videnskab/lavdosisacetylsalicylsyre-til-forebyggelse-af-praeeklampsi
UR - http://www.scopus.com/inward/record.url?scp=85192304877&partnerID=8YFLogxK
U2 - 10.61409/V10230682
DO - 10.61409/V10230682
M3 - Review
C2 - 38704715
SN - 0041-5782
VL - 186
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 18
M1 - V10230682
ER -